Viewing Study NCT04352166


Ignite Creation Date: 2025-12-24 @ 4:13 PM
Ignite Modification Date: 2025-12-26 @ 6:00 PM
Study NCT ID: NCT04352166
Status: SUSPENDED
Last Update Posted: 2025-02-14
First Post: 2020-04-16
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Extended-Release Buprenorphine vs. Sublingual Buprenorphine for the Treatment of Opioid Use Disorder
Sponsor: Frances R Levin
Organization:

Organization Data

Organization:
Class: OTHER
Study ID: 7963
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR_INVESTIGATOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators

Collaborators

Name Class View
None NIH View